cp wire

CP Wire Articles

Ascletis Acquires Rights to PH II NASH Candidate

Ascletis Pharma Inc. (Ascletis, 1672.HK) and 3-V Biosciences, Inc. (3-V Biosciences) jointly announced on 2/13/19 that Ascletis, through its subsidiary, and 3-V Biosciences have entered into an... read more

Wed, 02/13/19 - 05:02 pm
Microbiome Report for Week Ending 2/9/19

Seres Therapeutics Reduces Workforce by 30% to Focus on Advancing Clinical Assets... read more

Wed, 02/13/19 - 04:08 pm
China to Cut Value Added Tax on Rare Disease Drugs to 3%

Beginning on March 1, China will reduce the VAT on a group of 21 rare disease drugs from 16% to 3%. The government's announcement did not specify which drugs would be in the group. The move may... read more

Wed, 02/13/19 - 09:38 am
Sorrento and Yuhan Secure $40 Million for Immuno-Oncology Joint Venture

Yuhan Corporation (000100.KS; Yuhan) and Sorrento Therapeutics (Nasdaq: SRNE) announced on 2/12/19 that ImmuneOncia, a joint venture formed in September 2016, has completed a private equity... read more

Tue, 02/12/19 - 09:55 am
Xeris Announces $84 Million Offering

Xeris Pharmaceuticals announced on 2/11/19 that it filed a registration statement with the Securities and Exchange Commission (the “SEC”) relating to a proposed public offering of 5,000,000 shares... read more

Tue, 02/12/19 - 09:41 am

Pages